Testing effectiveness (Phase 2)WithdrawnNCT01543750What this trial is testing4-Aminopyridine in Episodic Ataxia Type 2Who this might be right forEpisodic Ataxia Type 2 University of California, Los Angeles
Not applicableStudy completedNCT05687474What this trial is testingBaby Detect : Genomic Newborn ScreeningWho this might be right forCongenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more Centre Hospitalier Universitaire de Liege 6,824
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Large-scale testing (Phase 3)Looking for participantsNCT07221292What this trial is testingPivotal Study of N-acetyl-L-leucine for CACNA1AWho this might be right forCACNA1ASpinocerebellar Ataxia Type 6Episodic Ataxia Type 2+1 more IntraBio Inc 60
Testing effectiveness (Phase 2)Study completedNCT00110045What this trial is testingCaspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 171
Not applicableStudy completedNCT01470729What this trial is testingBiomarkers in Autosomal Dominant Cerebellar AtaxiaWho this might be right forSpinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia, Autosomal Recessive 3+1 more Assistance Publique - Hôpitaux de Paris 102